High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.
Ketoconazole, an antifungal agent, inhibits in vitro C17-C20 lyase, an enzyme involved in androgen biosynthesis. Since adrenal and ovarian androgens are the main precursors of oestrogens in postmenopausal women, the endocrine and therapeutic effects of high dose ketoconazole (400 mg three times a da...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Nature Publishing Group
1988
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246803/ |